Method of vaccination for limiting articular inflammation in rheumatoid arthritis and multiple sclerosis by administering IL-23 peptides

摘要

The present invention relates to a pharmaceutical composition comprising as active substance, at least one compound comprising, or consisting of, a polypeptide which comprises, or consists of, at least 11 contiguous amino acids selected from X₁-S-D-I-F-X₂-G-E-P-X₃-L-X₄-P-X₅-X₆-X₇-X₈-X₉-Q-L (SEQ ID NO: 13).